参考文献
[1]BOSCH F X, et al. Primary liver cancer: worldwide incidence and trends[J]. Gastroenterology, 2004.
[2]JACQUES Ferlay, et al. Estimates of worldwide burden of cancer in 2008: Globocan 2008[J]. Int. J. Cancer, 2010.
[3]O’DONNELLK A, et al.c-Myc-regulated mi-croRNAs modulate E2F1 expression[J]. Nature, 2005.
[4]LEE Y, et al.The nuclear RNaseIII Drosha initiates xnicroRNA processing[J]. Nature, 2003.
[5]SEVIGNANI C, et al. Mammalian miRNAs: a small world for fine-tuning gene expression[J]. Mamm Genone, 006.
[6]RICHARD I G S, THIMMAIAH P C, et al. Human RISC couple miRNA biogenesis and Posttranscriptional gene silencing[J]. Cell, 2005.
[7]LEA A M, et al. Mir-290-295 deficiency in mice results in partially penetrant embryonic lethality and germ cell defects[J]. Proceedings of the National Academy of Sciences, 2011.
[8]NOHATA N, et al. miRNAsfunction as tumor suppressorsor oncogenes: Aberrant expression of miRNAs in head and neck squamous cell carcinoma[J]. Auris Nasus Larynx, 2013.
[9]HATFIELD S D, et al.Stem cell division is regulated by the miRNA pathway[J]. Nature, 2005.
[10]CALIN G A, et al. Human miRNA genes are frequenfly loeated at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci USA, 2004.
[11]LU J, et al. mi RNA expression Profiles classify human cancers[J]. Nature, 2005.
[12]BOTTOM A, et al. Identification of differentially expressed miRNAs by microarray: a possible role for miRNA genes in pituitary adenomas[J]. J Cell Physiol, 2007.
[13]CALIN G A, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci USA, 2002.
[14]CALDAS C, et al. Sizing up miRNA as cancer genes[J]. Nat Med, 2005.
[15]KLUIVER, et al. Lack of BIC and miRNA expression in primary cases of Burkitt lymphoma[J]. Genes Chromosomes Cancer, 2006.
[16]CHEN J, et al. miRNA-21 in breast cancer: diagnostic and prognostic potential[J]. Clin Transl Oncol, 2014
[17]JOHNSON S M, et al. The time of appearance of the C. elegans let-7 miRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter[J]. Dev Biol, 2003
[18]MICHAEL M Z, et al. Reduced accumulation of specific miRNAs in colorectal neoplasia[J]. Mol Cancer Res, 2003.
[19]IORIO M V, et al. miRNA gene expression deregulation in human breast cancer[J]. Cancer Res, 2005.
[20]KWAK P B, et al. The miRNA pathway and cancer[J]. Cancer Sci, 2010.
[21]SUN W, et al. Systematic-omics analysis of HBV associated liver diseases. Cancer Lett, 2009.
[22]GUI J, et al. Serum miRNA characterization identifies miR-885-Sp (Lond), 2011.
[23]FORNARI F, et al. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN/p21，PTEN, AKT3 and TIMP2[J]. J Pathol, 2012.
[24]XU T, et al. microRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology, 2009.
[25]XIONG Y, et al. Effects of nucroRNA-29 on apoptosis, tumorigenicity and prognosis of hepatocellular carcinoma[J]. Hepatology.2010.
[26]TURATO C, Simonato D, Quarts S, et al. 微小RNAs and SerpinB3 in hepatocellular carcinoma[J]. Life Sci, 2014.
[27]朱贵忠，等. 微小RNA在肝癌中的研究进展[J]. 现代预防医学，2011.